Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery

Launched by GÖTEBORG UNIVERSITY · Nov 27, 2018

Keywords

ClinConnect Summary

This clinical trial is investigating the effects of a care pathway that avoids or reduces the use of opioids for patients undergoing obesity surgery. Opioids are strong pain medications that can have serious side effects and might lead to other health issues, especially in certain groups of people, such as those with obesity. The study aims to see how well patients recover after surgery when they receive either opioid-free care or traditional care that includes opioids. Researchers will look at various aspects of recovery, including physical and mental well-being, pain management, and overall quality of life, for up to two years after surgery.

To participate in this trial, individuals must be at least 18 years old and scheduled to undergo certain types of obesity surgery, like gastric bypass or sleeve surgery. However, there are some exclusions, such as having serious heart or liver issues, being pregnant, or having a history of substance abuse. Participants can expect to be part of a study that prioritizes their comfort and recovery, with careful monitoring throughout the process. This trial is an important step in finding safer pain management options for patients undergoing obesity surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -Patients ≥18 years planned to undergo laparoscopic obesity surgery (GBP alt Sleeve surgery) at the selected site.
• Exclusion Criteria:
• • ASA\> III
• • Cardiovascular disease with bradycardia (\<50 bpm)
• • Serious liver disease failure
• • Insufficient knowledge of the Swedish language
• • Serious untreated psychiatric disease
• • Neurocognitive dysfunction
• • Pregnancy
• • Women of childbearing age without contraception
• • Malignant disease with expected short survival
• • Patients treated with opioids for chronic pain
• • Substance abuse
• • Hypersensitivity to Oxycodone, Esketamine, Dexmedetomidine, and Lidocaine
• • Pacemaker or ICD
• • Inability to fill in questionnaires
• • Decline participation,